Most bothersome symptom in women with genitourinary syndrome of menopause as a moderator of treatment effects
Conclusions: The approved dose of CE/BZA had clear benefits, particularly in women with pain with intercourse (the most common bothersome symptom), in whom it improved lubrication, superficial cell counts, and sexual functioning.
Source: Menopause - Category: OBGYN Tags: Original Articles Source Type: research
More News: Clinical Trials | Men | Menopause | Orthopaedics | Osteoporosis | Pain | Premarin | Statistics | Women